More information on the BIOFLEX-I clinical study is available at www.clinicaltrials.gov, identifier: NCT01319812.

About Pulsar-18*
Pulsar stents feature an innovative, highly flexible design coated with proBIO, a silicon carbide layer that improves the stent's hemocompatibility and biocompatibility - which is believed to contribute to its excellent clinical results. Pulsar-18 comes in diameters of 4 7 mm and lengths of 20-200 mm, all deliverable through a 4F sheath.
References:
[1] Bosiers M, et al. Journal of Endovascular Therapy. 2013, 20(6).
[2] Lichtenberg M, et al. Journal of Endovascular Therapy. 2014, 21(3).
Upon publication, please provide us with a copy.

Further information

All Photos and annexes together with the original article

Newsroom

Website
Your contact

Manuela Schildwächter
BIOTRONIK SE & Co. KG
Global Communications Manager
Tel: +49 (30) 68905-1466
E-Mail: presse@biotronik.com

Mark Johnson
Program Director, Vascular Intervention
BIOTRONIK, Inc.
6024 Jean Road
Lake Oswego, OR 97035
(800) 547-0394, Ext. 8007
(503) 451-8007
Email: mark.johnson@biotronik.com

About BIOTRONIK
One of the world's leading manufacturers of cardio- and endovascular medical devices, BIOTRONIK is headquartered in Berlin, Germany, and represented in over 100 countries by its global workforce of more than 5,600 employees. Several million patients have received BIOTRONIK implants designed to save and improve the quality of their lives, or have been treated with BIOTRONIK coronary and peripheral vascular intervention products. Since its development of the first German pacemaker in 1963, BIOTRONIK has engineered many innovations, including BIOTRONIK Home Monitoring®; the world's first 4F-compatible 200 mm peripheral stent*; Orsiro, the industry's first hybrid drug-eluting stent*; and the world's first implantable cardioverter-defibrillators with ProMRI® technology*.

*Investigational device: limited by US law to investigational use.

For more information, visit: www.biotronik.com

Back to HCB News

More HCB News